In addition to his clinical practice, Dr Tan is deeply involved in teaching and training of young haematologists. His appointment in the Residency Advisory Committee and continued affiliation with the academic hospitals allows him to contribute to post-graduate teaching, and to advise patients on participation in clinical trials for lymphoma and multiple myeloma.

Dr Tan is passionate about providing care for his patients. In recognition of his commitment to patient care, he received the Singapore Health Service Quality Service Gold Award in 2011, long service awards from the Singapore General Hospital and Raffles Hospital in 2008 and 2017 respectively, and the Courage Medal during the Singapore SARS epidemic in 2003. Dr Tan was a Major with the Singapore Armed Forces while serving national service. He held key appointments in the combat support hospital and volunteered for humanitarian missions to disaster areas in the region.

Dr Tan was elected into the International Myeloma Working Group in 2014 and also sits on the advisory panel of the International Myeloma Foundation’s Asia Myeloma Network. He is also a member of the Asia Lymphoma Study Group, the American Society of Haematology and the American Society of Clinical Oncology.  He has delivered more than 100 invited lectures on the treatment of lymphoma and multiple myeloma at international conferences and serves as an advisor to many expert panels on novel drugs development. He has led an international phase II study on novel treatment for T-cell lymphoma and the results are published in the Lancet Haematology. He is on the editorial board of several international peer reviewed scientific journals. Dr Tan’s work on immunotherapy in NK/T-cell lymphoma has led to its endorsement on the American NCCN cancer treatment guidelines in 2018. His scientific publications can be found here.